有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | [5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl 3-(4-chlorophenyl)sulfanylpropanoate | —— | C18H14Cl2N2O3S |
|
—— | (2R)-3-(3-bromophenyl)sulfanylpropane-1,2-diol | —— | C9H11BrO2S |
|
—— | 2-[(5-amino-1H-1,2,4-triazol-3-yl)sulfanyl]-1-[(3S,3aR,7Z)-3-thiophen-2-yl-7-(thiophen-2-ylmethylidene)-3a,4,5,6-tetrahydro-3H-indazol-2-yl]ethanone | —— | C20H20N6OS3 |
|
—— | (2S)-3-(3-bromophenyl)sulfanylpropane-1,2-diol | —— | C9H11BrO2S |
|
—— | N-[[(2R,3R)-2-propan-2-yloxolan-3-yl]methyl]-2-pyridin-4-ylsulfanylacetamide | —— | C15H22N2O2S |
|
—— | N-[[(2R,3S)-2-propan-2-yloxolan-3-yl]methyl]-2-pyridin-4-ylsulfanylacetamide | —— | C15H22N2O2S |
|
—— | N-[[(2S,3R)-2-propan-2-yloxolan-3-yl]methyl]-2-pyridin-4-ylsulfanylacetamide | —— | C15H22N2O2S |
|
—— | N-[[(2S,3S)-2-propan-2-yloxolan-3-yl]methyl]-2-pyridin-4-ylsulfanylacetamide | —— | C15H22N2O2S |
|
—— | (2S)-3-(2-phenylpyrimidin-4-yl)sulfanylpropane-1,2-diol | —— | C13H14N2O2S |
|
—— | (2R)-3-(2-phenylpyrimidin-4-yl)sulfanylpropane-1,2-diol | —— | C13H14N2O2S |
|
—— | (3R)-1-cyclopropyl-3-[[4-(2-thiophen-2-ylethyl)-1,2,4-triazol-3-yl]sulfanyl]pyrrolidin-2-one | —— | C15H18N4OS2 |
|
—— | (3S)-1-cyclopropyl-3-[[4-(2-thiophen-2-ylethyl)-1,2,4-triazol-3-yl]sulfanyl]pyrrolidin-2-one | —— | C15H18N4OS2 |
|
—— | (3S)-1-cyclopropyl-3-[1-(2-thiophen-2-ylethyl)tetrazol-5-yl]sulfanylpyrrolidin-2-one | —— | C14H17N5OS2 |
|
—— | 2-propan-2-ylsulfonyl-N-[(1R,2S)-2,4,4-trimethylcyclohexyl]acetamide | —— | C14H27NO3S |
|
—— | 2-propan-2-ylsulfonyl-N-[(1R,2R)-2,4,4-trimethylcyclohexyl]acetamide | —— | C14H27NO3S |
|
—— | 2-propan-2-ylsulfonyl-N-[(1S,2S)-2,4,4-trimethylcyclohexyl]acetamide | —— | C14H27NO3S |
|
—— | N-[(1S,3R)-3-ethylsulfanylcyclohexyl]-2-pyridin-4-ylsulfanylacetamide | —— | C15H22N2OS2 |
|
—— | N-[(1R,3S)-3-ethylsulfanylcyclohexyl]-2-pyridin-4-ylsulfanylacetamide | —— | C15H22N2OS2 |
|
—— | N-[(1S,3S)-3-ethylsulfanylcyclohexyl]-2-pyridin-4-ylsulfanylacetamide | —— | C15H22N2OS2 |
|
—— | 1-[(2S)-3,3-dimethylbutan-2-yl]-3-[[1-(methylsulfonylmethyl)cyclopropyl]methyl]urea | —— | C13H26N2O3S |
|
—— | 3-[(2R)-oxan-2-yl]-5-[(2R)-pentan-2-yl]sulfanyl-1,2,4-triazol-4-amine | —— | C12H22N4OS |
|
—— | (2S)-2-[2-[(5-propyl-1H-1,2,4-triazol-3-yl)sulfanyl]ethyl]cyclopentan-1-one | —— | C12H19N3OS |
|
—— | 3-(3,5-dimethylpyrazol-1-yl)-5-[(2S)-pentan-2-yl]sulfanyl-1,2,4-triazol-4-amine | —— | C12H20N6S |
|
—— | 3-(3,5-dimethylpyrazol-1-yl)-5-[(2R)-pentan-2-yl]sulfanyl-1,2,4-triazol-4-amine | —— | C12H20N6S |
|
—— | (2R)-2-[2-[(5-propyl-1H-1,2,4-triazol-3-yl)sulfanyl]ethyl]cyclopentan-1-one | —— | C12H19N3OS |
|
—— | 3-[(2R)-oxan-2-yl]-5-[(2S)-pentan-2-yl]sulfanyl-1,2,4-triazol-4-amine | —— | C12H22N4OS |
|
—— | 1-[(2R)-3,3-dimethylbutan-2-yl]-3-[[1-(methylsulfonylmethyl)cyclopropyl]methyl]urea | —— | C13H26N2O3S |
|
—— | 3-[(2S)-oxan-2-yl]-5-[(2R)-pentan-2-yl]sulfanyl-1,2,4-triazol-4-amine | —— | C12H22N4OS |
|
—— | 3-[(2S)-oxan-2-yl]-5-[(2S)-pentan-2-yl]sulfanyl-1,2,4-triazol-4-amine | —— | C12H22N4OS |
|
—— | N-[(1S,2S)-2-ethylsulfanylcyclopentyl]-2-pyridin-4-ylsulfanylacetamide | —— | C14H20N2OS2 |
|
—— | (6E)-5-imino-3-methylsulfanyl-6-[(5-phenylsulfanylfuran-2-yl)methylidene]-[1,2,4]thiadiazolo[4,5-a]pyrimidin-7-one | —— | C17H12N4O2S3 |
|
—— | N-[(1R,2S)-2-ethylsulfanylcyclopentyl]-2-pyridin-4-ylsulfanylacetamide | —— | C14H20N2OS2 |
|
—— | N-[(1R,2R)-2-ethylsulfanylcyclopentyl]-2-pyridin-4-ylsulfanylacetamide | —— | C14H20N2OS2 |
|
—— | N-[(1S,2R)-2-ethylsulfanylcyclopentyl]-2-pyridin-4-ylsulfanylacetamide | —— | C14H20N2OS2 |
|
—— | (3R)-N-(2-pyrrol-1-ylethyl)-2,3-dihydro-1-benzothiophene-3-carboxamide | —— | C15H16N2OS |
|
—— | (3R)-N-[2-(3-amino-1,2,4-oxadiazol-5-yl)ethyl]-2,3-dihydro-1-benzothiophene-3-carboxamide | —— | C13H14N4O2S |
|
—— | (3R)-N-[[1-(cyanomethyl)piperidin-4-yl]methyl]-2,3-dihydro-1-benzothiophene-3-carboxamide | —— | C17H21N3OS |
|
—— | (3S)-N-[2-(3-amino-1,2,4-oxadiazol-5-yl)ethyl]-2,3-dihydro-1-benzothiophene-3-carboxamide | —— | C13H14N4O2S |
|
—— | (3S)-N-[[1-(cyanomethyl)piperidin-4-yl]methyl]-2,3-dihydro-1-benzothiophene-3-carboxamide | —— | C17H21N3OS |
|
—— | N-methyl-N-[(4-methylsulfanylphenyl)methyl]-2-(5-thiophen-3-yltetrazol-2-yl)acetamide | —— | C16H17N5OS2 |
|
—— | N-[2-[(5E)-2,4-dioxo-5-(pyridin-3-ylmethylidene)-1,3-thiazolidin-3-yl]ethyl]-2-[[5-(prop-2-enylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide | —— | C18H18N6O3S3 |
|
—— | (2E,4Z)-2,4-bis[(4-methylsulfanylphenyl)methylidene]thiolan-3-one | —— | C20H18OS3 |
|
—— | (2Z,4E)-2,4-bis[(4-methylsulfanylphenyl)methylidene]thiolan-3-one | —— | C20H18OS3 |
|
—— | 3-(2-methoxyethyl)-5-[[(5S)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-yl]sulfanyl]-1,2,4-triazol-4-amine | —— | C16H22N4OS |
|
—— | (3S)-3-(3-chlorophenyl)sulfanyl-1-(oxan-4-yl)pyrrolidin-2-one | —— | C15H18ClNO2S |
|
—— | 3-(2-methoxyethyl)-5-[[(5R)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-yl]sulfanyl]-1,2,4-triazol-4-amine | —— | C16H22N4OS |
|
—— | 5-[[2-[(1R)-1-methoxyethyl]-1,3-thiazol-4-yl]methylsulfanyl]-4-propan-2-yl-1,2,4-triazol-3-amine | —— | C12H19N5OS2 |
|
—— | 2-[3-[(1R)-1-(5-tert-butyl-1,3-oxazol-2-yl)ethyl]sulfanyl-5-methyl-1,2,4-triazol-4-yl]acetamide | —— | C14H21N5O2S |
|
—— | 1-[[5-[[(5R)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-yl]sulfanyl]-1,3,4-oxadiazol-2-yl]methyl]pyrrolidin-2-one | —— | C18H21N3O2S |
|
—— | 1-ethyl-2-[[2-[(1S)-1-methoxyethyl]-1,3-thiazol-4-yl]methylsulfanyl]pyrimidin-4-one | —— | C13H17N3O2S2 |
|